CAM
Cormorant Asset Management’s Sarepta Therapeutics SRPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-125,000
| Closed | -$19.8M | – | 53 |
|
|
2024
Q2 | $19.8M | Buy |
+125,000
| New | +$19.8M | 1.14% | 25 |
|
|
2023
Q3 | – | Sell |
-130,000
| Closed | -$14.9M | – | 61 |
|
|
2023
Q2 | $14.9M | Buy |
130,000
+20,000
| +18% | +$2.29M | 0.83% | 30 |
|
|
2023
Q1 | $15.2M | Sell |
110,000
-90,000
| -45% | -$12.4M | 1% | 27 |
|
|
2022
Q4 | $25.9M | Hold |
200,000
| – | – | 1.73% | 18 |
|
|
2022
Q3 | $22.1M | Buy |
+200,000
| New | +$22.1M | 1.55% | 24 |
|
|
2021
Q2 | – | Sell |
-70,000
| Closed | -$5.22M | – | 122 |
|
|
2021
Q1 | $5.22M | Hold |
70,000
| – | – | 0.12% | 89 |
|
|
2020
Q4 | $11.9M | Sell |
70,000
-15,000
| -18% | -$2.56M | 0.28% | 54 |
|
|
2020
Q3 | $11.9M | Sell |
85,000
-25,000
| -23% | -$3.51M | 0.46% | 48 |
|
|
2020
Q2 | $17.6M | Sell |
110,000
-40,000
| -27% | -$6.41M | 0.67% | 43 |
|
|
2020
Q1 | $14.7M | Sell |
150,000
-100,000
| -40% | -$9.78M | 0.68% | 37 |
|
|
2019
Q4 | $32.3M | Buy |
250,000
+28,300
| +13% | +$3.65M | 1.29% | 22 |
|
|
2019
Q3 | $16.7M | Sell |
221,700
-3,300
| -1% | -$249K | 1.02% | 28 |
|
|
2019
Q2 | $34.2M | Sell |
225,000
-75,000
| -25% | -$11.4M | 1.96% | 15 |
|
|
2019
Q1 | $35.8M | Buy |
300,000
+210,000
| +233% | +$25M | 2.42% | 12 |
|
|
2018
Q4 | $9.82M | Buy |
+90,000
| New | +$9.82M | 0.8% | 33 |
|